SHORT STATURE CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA)

Clinical trials for SHORT STATURE CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA) explained in plain language.

Never miss a new study

Get alerted when new SHORT STATURE CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA) trials appear

Sign up with your email to follow new studies for SHORT STATURE CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Weekly shot could replace daily injections for short kids

Disease control Ongoing

This study compares a new weekly growth hormone injection (somapacitan) against the standard daily injection (Norditropin®) for children who were born small and remained short. Over 62 children will receive either treatment for 5 years to see if the weekly option works as well an…

Matched conditions: SHORT STATURE CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA)

Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

SHORT STATURE CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA)

Get alerted when new SHORT STATURE CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA) trials appear

Weekly shot could replace daily injections for short kids